Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS Plunges 6%; BSE HEALTHCARE Index Down 0.1%
Thu, 26 Sep 11:19

NEULAND LABS Plunges 6%; BSE HEALTHCARE Index Down 0.1%Image source: bluebay2014/www.istockphoto.com

NEULAND LABS share price has plunged 6% and is presently trading at Rs 11,708.8.

Meanwhile, the BSE HEALTHCARE index is at 44,127.4 (down 0.1%).

Among the top losers in the BSE HEALTHCARE index today are DR. LAL PATHLABS (down 2.6%) and Natco Pharma (down 1.9%).

FORTIS HEALTHCARE (up 1.9%) and ALEMBIC PHARMA (up 1.8%) are among the top gainers today.

Over the last one year, NEULAND LABS has moved up from Rs 3,805.7 to Rs 11,708.8, registering a gain of Rs 7,903.1 (up 207.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,800.9 to 44,127.4, registering a gain of 58.7% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 186.7%), SUVEN PHARMACEUTICALS (up 124.7%) and Glenmark Pharma (up 114.4%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 85,388.2 (up 0.3%).

The top gainers among the BSE Sensex today are Maruti Suzuki (up 3.0%) and Bajaj Finserv (up 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and Power Grid Corp..

In the meantime, NSE Nifty is at 26,073.3 (up 0.3%). Maruti Suzuki and Bajaj Finserv are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,023.7 to 85,388.2, registering a gain of 19,364.6 points (up 29.3%).

NEULAND LABS Financial Update...

NEULAND LABS net profit grew 58.2% YoY to Rs 979 million for the quarter ended June 2024, compared to a profit of Rs 619 million a year ago. Net sales rose 21.1% to Rs 4,396 million during the period as against Rs 3,630 million in April-June 2023.

For the year ended March 2024, NEULAND LABS reported 83.5% increase in net profit to Rs 3,001 million compared to net profit of Rs 1,635 million during FY23. Revenue of the company grew 30.8% to Rs 15,586 million during FY24.

The current Price to earnings ratio of NEULAND LABS, based on rolling 12 month earnings, stands at 44.7.


Equitymaster requests your view! Post a comment on "NEULAND LABS Plunges 6%; BSE HEALTHCARE Index Down 0.1%". Click here!